Joseph P. Hagan
2018 - Regulus Therapeutics
In 2018, Joseph P. Hagan earned a total compensation of $2.3M as President & Chief Executive Officer at Regulus Therapeutics, a 22% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $234,000 |
|---|---|
| Option Awards | $1,580,018 |
| Salary | $520,000 |
| Other | $4,250 |
| Total | $2,338,268 |
Hagan received $1.6M in option awards, accounting for 68% of the total pay in 2018.
Hagan also received $234K in non-equity incentive plan, $520K in salary and $4.3K in other compensation.
Rankings
In 2018, Joseph P. Hagan's compensation ranked 4,962nd out of 14,244 executives tracked by ExecPay. In other words, Hagan earned more than 65.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,962 out of 14,244 | 65th |
Division Manufacturing | 1,867 out of 5,765 | 68th |
Major group Chemicals And Allied Products | 685 out of 2,128 | 68th |
Industry group Drugs | 574 out of 1,817 | 68th |
Industry Pharmaceutical Preparations | 441 out of 1,391 | 68th |
Source: SEC filing on July 1, 2019.
Hagan's colleagues
We found two more compensation records of executives who worked with Joseph P. Hagan at Regulus Therapeutics in 2018.
News
Regulus Therapeutics CEO Joseph Hagan's 2021 pay falls 22% to $1.8M
April 27, 2022
Regulus Therapeutics CEO Joseph Hagan's 2020 pay rises 16% to $2.3M
April 30, 2021
Regulus Therapeutics CEO Joseph Hagan's 2019 pay slips 14% to $2M
April 29, 2020
Regulus Therapeutics CEO Joseph Hagan's 2018 pay jumps 22% to $2.3M
July 1, 2019